EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-11.93%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$3.06B
AUM Growth
+$226M
(+8%)
Cap. Flow
+$578M
Cap. Flow
% of AUM
18.9%
Top 10 Holdings %
Top 10 Hldgs %
83.2%
Holding
374
New
73
Increased
133
Reduced
109
Closed
49
Top Buys
| 1 |
Alibaba
BABA
|
$315M |
| 2 |
Baidu
BIDU
|
$74M |
| 3 |
JD.com
JD
|
$72M |
| 4 |
NetEase
NTES
|
$47.9M |
| 5 |
Pinduoduo
PDD
|
$39.6M |
Top Sells
| 1 |
NIO
NIO
|
$10.7M |
| 2 |
KC
Kingsoft Cloud Holdings
KC
|
$9.2M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$7.55M |
| 4 |
Invesco QQQ Trust
QQQ
|
$7.48M |
| 5 |
United States Brent Oil Fund
BNO
|
$6.73M |
Sector Composition
| 1 | Consumer Discretionary | 63.45% |
| 2 | Communication Services | 21.89% |
| 3 | Technology | 6.77% |
| 4 | Healthcare | 2.13% |
| 5 | Financials | 1.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
United Therapeutics
UTHR
$18.1B
| $278K | 0.01% |
+1,551
| New | +$278K |
|
|
ISEE
227
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $276K | 0.01% |
16,370
+4,542
| +38% | +$76.6K |
|
228
Amicus Therapeutics
FOLD
$2.46B
| $273K | 0.01% |
28,875
+12,006
| +71% | +$114K |
|
229
Heron Therapeutics
HRTX
$201M
| $273K | 0.01% |
47,763
+29,396
| +160% | +$168K |
|
230
Lowe's Companies
LOW
$151B
| $273K | 0.01% |
1,351
-180
| -12% | -$36.4K |
|
|
MRTX
231
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $273K | 0.01% |
+3,321
| New | +$273K |
|
232
BioMarin Pharmaceuticals
BMRN
$11.1B
| $272K | 0.01% |
+3,531
| New | +$272K |
|
233
BioCryst Pharmaceuticals
BCRX
$1.74B
| $271K | 0.01% |
16,641
+1,756
| +12% | +$28.6K |
|
234
Novavax
NVAX
$1.28B
| $271K | 0.01% |
+3,676
| New | +$271K |
|
235
Ligand Pharmaceuticals
LGND
$3.25B
| $270K | 0.01% |
+3,846
| New | +$270K |
|
236
Cigna
CI
$81.5B
| $269K | 0.01% |
1,121
-184
| -14% | -$44.2K |
|
237
Sarepta Therapeutics
SRPT
$1.96B
| $269K | 0.01% |
+3,446
| New | +$269K |
|
238
Zoom
ZM
$25B
| $269K | 0.01% |
2,298
| – | – |
|
|
BHVN
239
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $268K | 0.01% |
2,259
+520
| +30% | +$61.7K |
|
240
Celldex Therapeutics
CLDX
$1.52B
| $267K | 0.01% |
+7,838
| New | +$267K |
|
241
Edwards Lifesciences
EW
$47.5B
| $266K | 0.01% |
2,258
-127
| -5% | -$15K |
|
242
Kymera Therapeutics
KYMR
$3.11B
| $264K | 0.01% |
6,228
+3,078
| +98% | +$130K |
|
243
Cytokinetics
CYTK
$6.34B
| $263K | 0.01% |
7,154
+2,350
| +49% | +$86.4K |
|
244
Prothena Corp
PRTA
$460M
| $263K | 0.01% |
+7,202
| New | +$263K |
|
245
Becton Dickinson
BDX
$55.1B
| $262K | 0.01% |
1,009
-154
| -13% | -$40K |
|
246
Agios Pharmaceuticals
AGIO
$2.09B
| $260K | 0.01% |
+8,923
| New | +$260K |
|
247
Gartner
IT
$18.6B
| $260K | 0.01% |
875
+67
| +8% | +$19.9K |
|
248
Allogene Therapeutics
ALLO
$255M
| $258K | 0.01% |
+28,315
| New | +$258K |
|
249
CDW
CDW
$22.2B
| $258K | 0.01% |
1,441
+112
| +8% | +$20.1K |
|
250
Direxion Daily Gold Miners Index Bull 2X Shares
NUGT
$847M
| $258K | 0.01% |
3,646
-20,455
| -85% | -$1.45M |
|